Amdocs Limited (DOX) Stock Forecast
DOX analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 6 analysts
- Price target
- $79.25 average of analyst targets
- Upside to target
- +32.0% from the latest close
- Next earnings
- November 10, 2026 EPS estimate $1.78
- 52-week range
- $49.87 – $85.49
DOX analyst ratings
6 analystsNumber of analysts at each rating.
DOX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
DOX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next quarter (Dec '26) | $1.93 | $1.91 | $1.96 | $1.81 | +6.8% | 4 |
| Current fiscal year (FY2026) | $7.42 | $7.40 | $7.45 | $6.99 | +6.2% | 6 |
| Next fiscal year (FY2027) | $8.03 | $7.83 | $8.29 | $7.42 | +8.2% | 6 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
DOX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next quarter (Dec '26) | $1.20B | $1.20B | $1.20B | +3.8% | 3 |
| Current fiscal year (FY2026) | $4.70B | $4.70B | $4.71B | +3.7% | 5 |
| Next fiscal year (FY2027) | $4.85B | $4.81B | $4.87B | +3.2% | 5 |
DOX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
DOX revenue: reported and forecast
DOX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next quarter (Dec '26) | $1.95 | $1.95 | $1.96 | $1.96 | $1.93 | −0.9% | 0 up · 2 down |
| Current fiscal year (FY2026) | $7.43 | $7.43 | $7.41 | $7.42 | $7.42 | −0.2% | 3 up · 2 down |
| Next fiscal year (FY2027) | $8.09 | $8.09 | $8.06 | $8.02 | $8.03 | −0.8% | 3 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
DOX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; DOX beat in 11 of 12.
What analysts expect from DOX
6 analysts cover Amdocs; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $79.25, 32.0% above the latest close of $60.06. Analysts expect earnings of $7.42 per share for FY2026, +6.2% from a year earlier. For FY2027 the average estimate is $8.03 per share on revenue of $4.8 billion. Amdocs beat the EPS estimate in 11 of the last 12 quarters.
Related: DOX income statement, DOX key metrics, DOX chart. See the DOX stock overview for the latest quote and news.
DOX forecast FAQ
What is Amdocs's price target?
The average analyst price target for Amdocs is $79.25, 32.0% above the latest close of $60.06.
Is Amdocs a buy, hold or sell?
Of 6 analysts covering Amdocs, 3 rate it a strong buy, 0 a buy, 3 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Amdocs's EPS forecast?
Analysts forecast $7.42 per share for FY2026 (range $7.40 to $7.45); for FY2027 the estimate is $8.03.
What is Amdocs's revenue forecast?
The average revenue estimate for FY2026 is $4.7 billion, growth of 3.7%; for FY2027 it is $4.8 billion.
When does Amdocs report earnings?
Amdocs is expected to report results for the quarter ending September 30, 2026 on November 10, 2026 after the market closes; the EPS estimate is $1.78.
Does Amdocs usually beat earnings estimates?
Amdocs reported EPS at or above the analyst estimate in 11 of the last 12 quarters.